SelSym Biotech
PrivateLast Round
Seed
Jul 15, 2026
Total Funding Raised
$8.57M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
SelSym Biotech is a biotechnology company developing synthetic platelet-mimetic therapeutics for hemorrhage control and wound healing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Defense Tech
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SelSym Biotech Comparables
Compare SelSym Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hemostatics Pharmaceuticals S.L. | 61% | |
| Melanyze, Inc. | 53% |
SelSym Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 15, 2026 | ||||
| Grant | Apr 16, 2024 | ||||
| Seed | Apr 16, 2024 | ||||
| Grant | Sep 22, 2022 | ||||
| Debt | Jun 1, 2022 | ||||
Grant | Sep 15, 2021 |
SelSym Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| United States Department of Defense | Grant |
| NIH RADx | Grant |
| U.S. Department of War | Grant |
| Persephoni BioSciences | Seed |
| North Carolina Biotechnology Center | Debt |
| National Heart, Lung, and Blood Institute | Grant |
| One North Carolina Small Business Program | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 15, 2026
$500K Seed Round raised.
- Jul 16, 2025
Grew 50% QoQ from 6 to 9 employees.
SelSym Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SelSym Biotech's valuation, stock price, and market status.
Is SelSym Biotech a public or private company?
SelSym Biotech is a private company.
What is the current stock price of SelSym Biotech?
SelSym Biotech is a private company, so its shares have no public market price. Caplight tracks SelSym Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SelSym Biotech worth (valuation)?
Valuation information for SelSym Biotech is not publicly available.
Can I buy SelSym Biotech stock?
SelSym Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SelSym Biotech's last funding round?
SelSym Biotech's most recent funding round was Seed on July 15, 2026.
Who are the main investors in SelSym Biotech?
Key investors in SelSym Biotech include Persephoni BioSciences.
Will SelSym Biotech IPO soon?
No public IPO plans have been announced for SelSym Biotech.
How can I track SelSym Biotech secondary market activity?
Caplight tracks bids, offers, and trades in SelSym Biotech's shares on secondary markets.